https://wikimd.org/index.php?action=history&feed=atom&title=Michelle_MonjeMichelle Monje - Revision history2026-04-27T01:35:29ZRevision history for this page on the wikiMediaWiki 1.44.2https://wikimd.org/index.php?title=Michelle_Monje&diff=5811138&oldid=prevPrab: CSV import2024-05-22T21:48:51Z<p>CSV import</p>
<p><b>New page</b></p><div>[[File:Michelle_Monje_for_the_NINDS.jpg|thumb|Michelle Monje for the NINDS]] '''Michelle Monje''' is an American [[neuroscientist]] and [[neuro-oncologist]] known for her research on [[glioma]]s, particularly [[diffuse intrinsic pontine glioma]] (DIPG). She is a professor of [[neurology]] at [[Stanford University]] and a leading figure in the study of the interactions between [[neurons]] and [[cancer]] cells in the [[brain]].<br />
<br />
== Early Life and Education ==<br />
Michelle Monje was born in [[California]]. She completed her undergraduate studies at [[Vassar College]], where she earned a [[Bachelor of Arts]] in [[biochemistry]]. She then pursued her [[Doctor of Medicine|MD]] and [[Doctor of Philosophy|PhD]] at [[Stanford University]], focusing on [[neuroscience]].<br />
<br />
== Career ==<br />
After completing her medical and doctoral training, Monje joined the faculty at [[Stanford University]] as an assistant professor in the Department of [[Neurology]] and [[Neurological Sciences]]. Her research has significantly advanced the understanding of how [[neural activity]] influences the growth and development of [[glioma]]s.<br />
<br />
== Research ==<br />
Monje's research primarily focuses on the mechanisms by which [[neuronal activity]] affects [[glioma]] growth. Her work has demonstrated that [[synaptic]] and [[neuronal]] activity can promote the proliferation of [[glioma]] cells. This groundbreaking research has opened new avenues for potential therapeutic strategies targeting the [[tumor microenvironment]].<br />
<br />
One of her notable contributions is the identification of the role of [[neurotransmitters]] in [[glioma]] progression. Her lab has shown that [[glutamate]] released by [[neurons]] can stimulate [[glioma]] cell growth, suggesting that targeting [[neurotransmitter]] pathways could be a viable approach to treating these aggressive [[brain tumors]].<br />
<br />
== Awards and Honors ==<br />
Michelle Monje has received numerous awards for her contributions to [[neuroscience]] and [[neuro-oncology]], including the [[National Institutes of Health]] (NIH) Director's New Innovator Award and the [[American Association for Cancer Research]] (AACR) NextGen Grant for Transformative Cancer Research.<br />
<br />
== Personal Life ==<br />
Monje is married and has children. She balances her professional career with her family life and is an advocate for women in [[science]] and [[medicine]].<br />
<br />
== See Also ==<br />
* [[Neuroscience]]<br />
* [[Neuro-oncology]]<br />
* [[Glioma]]<br />
* [[Stanford University]]<br />
* [[Neurotransmitter]]<br />
* [[Brain tumor]]<br />
<br />
== References ==<br />
{{Reflist}}<br />
<br />
== External Links ==<br />
{{Stanford University}}<br />
<br />
{{Authority control}}<br />
<br />
[[Category:Living people]]<br />
[[Category:American neuroscientists]]<br />
[[Category:American oncologists]]<br />
[[Category:Women neuroscientists]]<br />
[[Category:Stanford University faculty]]<br />
[[Category:Vassar College alumni]]<br />
[[Category:Stanford University alumni]]<br />
[[Category:Year of birth missing (living people)]]<br />
[[Category:Place of birth missing (living people)]]<br />
<br />
{{medicine-stub}}</div>Prab